Cargando…
Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus
BACKGROUND: Our previous research indicated the excellent in vitro antibacterial activity of Eravacycline (Erava) and its heteroresistance frequency against clinical Staphylococcus aureus isolates. In this study, we further aimed to investigate the mechanisms of Erava resistance and heteroresistance...
Autores principales: | Wang, Zhanwen, Lin, Zhiwei, Bai, Bing, Xu, Guangjian, Li, Peiyu, Yu, Zhijian, Deng, Qiwen, Shang, Yongpeng, Zheng, Jinxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329441/ https://www.ncbi.nlm.nih.gov/pubmed/32611319 http://dx.doi.org/10.1186/s12866-020-01869-6 |
Ejemplares similares
-
In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding Protein
por: Bai, Bing, et al.
Publicado: (2019) -
Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China
por: Wen, Zewen, et al.
Publicado: (2020) -
In Vitro Activity of the Novel Tetracyclines, Tigecycline, Eravacycline, and Omadacycline, Against Moraxella catarrhalis
por: Sun, Xiang, et al.
Publicado: (2021) -
Loratadine inhibits Staphylococcus aureus virulence and biofilm formation
por: Zheng, Jinxin, et al.
Publicado: (2022) -
Omadacycline Efficacy against Enterococcus faecalis Isolated in China: In Vitro Activity, Heteroresistance, and Resistance Mechanisms
por: Lin, Zhiwei, et al.
Publicado: (2020)